Independent and joint associations of cardiometabolic multimorbidity and depression on cognitive function: findings from multi-regional cohorts and generalisation from community to clinic.

Journal: The Lancet regional health. Western Pacific

Volume: 51

Issue: 

Year of Publication: 

Affiliated Institutions:  School of Public Health, The Second Affiliated Hospital of School of Medicine, Zhejiang University, Hangzhou, China. Centre for Healthy Brain Ageing, Discipline of Psychiatry & Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, Australia. Memory, Ageing, and Cognition Centre (MACC), Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Singapore Eye Research Institute, Singapore National Eye Centre, Singapore. Raffles Neuroscience Centre, Raffles Hospital, Singapore. Center for Studies in Public Health and Aging, Belo Horizonte, Brazil. Instituto Rene' Rachou, Fundac¸ão Oswaldo Cruz, Rio de Janeiro, Brazil. Department of Psychiatry- Federal University of Sao Paulo- UNIFESP, Sao Paulo, Brazil. Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. Institut for Neurosciences of Montpellier, University Montpellier, National Institute for Health and Medical Research, Montpellier, France. First Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens, Athens, Greece. Department of Nutrition and Dietetics, Harokopio University, Athens, Greece. Lab of Neuropsychology & Behavioral Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece. World Health Organization Collaborating Centre for Research and Training in Mental Health, Neuroscience, and Substance Abuse, Department of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria. Department of Psychiatry and Indiana Alzheimer Disease Center Indiana School of Medicine, Indianapolis, USA. Indiana Alzheimer Disease Research Center, Indianapolis. Department of Physical Therapy, Federal University of Rio Grande do Norte, Brazil. School of Rehabilitation Therapy, Kingston, Ontario, Canada. Research Group on Geriatrics and Gerontology. Faculty of Health Sciences, Universidad de Caldas, Manizales, Colombia. Golgi Cenci Foundation, Abbiategrasso, Italy. Institute of Social Medicine, Occupational Health and Public Health, Medical Faculty, University of Leipzig, Leipzig, Germany. Departments of Psychiatry, Neurology, and Epidemiology, School of Medicine and School of Public Health, University of Pittsburgh, USA. Department of Psychiatry, School of Medicine, University of Pittsburgh, USA. Departments of Medicine and Bioostatistics, School of Medicine and School of Public Health, University of Pittsburgh, USA. Robert N. Butler Columbia Aging Center, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA. Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, , Madrid, Spain. Department of Medicine and Psychiatry, Universidad de Zaragoza, Zaragoza, Spain. Department of Preventive Medicine and Public Health, Universidad de Zaragoza, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza CIBERSAM, Madrid, Spain.

Abstract summary 

Cardiometabolic multimorbidity (CMM) and depression are often co-occurring in older adults and associated with neurodegenerative outcomes. The present study aimed to estimate the independent and joint associations of CMM and depression on cognitive function in multi-regional cohorts, and to validate the generalizability of the findings in additional settings, including clinical.Data harmonization was performed across 14 longitudinal cohort studies within the Cohort Studies of Memory in an International Consortium (COSMIC) group, spanning North America, South America, Europe, Africa, Asia, and Australia. Three external validation studies with distinct settings were employed for generalization. Participants were eligible for inclusion if they had data for CMM and were free of dementia at baseline. Baseline CMM was defined as: 1) CMM 5, ≥2 among hypertension, hyperlipidemia, diabetes, stroke, and heart disease and 2) CMM 3 (aligned with previous studies), ≥2 among diabetes, stroke, and heart disease. Baseline depression was primarily characterized by binary classification of depressive symptom measurements, employing the Geriatric Depression Scale and the Center for Epidemiological Studies-Depression scale. Global cognition was standardized as z-scores through harmonizing multiple cognitive measures. Longitudinal cognition was calculated as changes in global cognitive z-scores. A pooled individual participant data (IPD) analysis was utilized to estimate the independent and joint associations of CMM and depression on cognitive outcomes in COSMIC studies, both cross-sectionally and longitudinally. Repeated analyses were performed in three external validation studies.Of the 32,931 older adults in the 14 COSMIC cohorts, we included 30,382 participants with complete data on baseline CMM, depression, and cognitive assessments for cross-sectional analyses. Among them, 22,599 who had at least 1 follow-up cognitive assessment were included in the longitudinal analyses. The three external studies for validation had 1964 participants from 3 multi-ethnic Asian older adult cohorts in different settings (community-based, memory clinic, and post-stroke study). In COSMIC studies, each of CMM and depression was independently associated with cross-sectional and longitudinal cognitive function, without significant interactions between them (s > 0.05). Participants with both CMM and depression had lower cross-sectional cognitive performance (e.g. β = -0.207, 95% CI = (-0.255, -0.159) for CMM5 (+)/depression (+)) and a faster rate of cognitive decline (e.g. β = -0.040, 95% CI = (-0.047, -0.034) for CMM5 (+)/depression (+)), compared with those without either condition. These associations remained consistent after additional adjustment for APOE genotype and were robust in two-step random-effects IPD analyses. The findings regarding the joint association of CMM and depression on cognitive function were reproduced in the three external validation studies.Our findings highlighted the importance of investigating age-related co-morbidities in a multi-dimensional perspective. Targeting both cardiometabolic and psychological conditions to prevent cognitive decline could enhance effectiveness.Natural Science Foundation of China and National Institute on Aging/National Institutes of Health.

Authors & Co-authors:  Zhao Xuhao X Xu Xiaolin X Yan Yifan Y Lipnicki Darren M DM Pang Ting T Crawford John D JD Chen Christopher C Cheng Ching-Yu CY Venketasubramanian Narayanaswamy N Chong Eddie E Blay Sergio Luis SL Lima-Costa Maria Fernanda MF Castro-Costa Erico E Lipton Richard B RB Katz Mindy J MJ Ritchie Karen K Scarmeas Nikolaos N Yannakoulia Mary M Kosmidis Mary H MH Gureje Oye O Ojagbemi Akin A Bello Toyin T Hendrie Hugh C HC Gao Sujuan S Guerra Ricardo Oliveira RO Auais Mohammad M Gomez José Fernando JF Rolandi Elena E Davin Annalisa A Rossi Michele M Riedel-Heller Steffi G SG Löbner Margit M Roehr Susanne S Ganguli Mary M Jacobsen Erin P EP Chang Chung-Chou H CH Aiello Allison E AE Ho Roger R Sanchez-Juan Pascual P Valentí-Soler Meritxell M Ser Teodoro Del TD Lobo Antonio A De-la-Cámara Concepción C Lobo Elena E Sachdev Perminder S PS Xu Xin X

Study Outcome 

Source Link: Visit source

Statistics
Citations :  van Dyck C.H., Swanson C.J., Aisen P., et al. Lecanemab in early Alzheimer's disease. N Engl J Med. 2023;388:9–21.
Authors :  47
Identifiers
Doi : 101198
SSN : 2666-6065
Study Population
Male,Female
Mesh Terms
Other Terms
Cardiometabolic multimorbidity;Cognitive decline;Depression;Multi-regional study
Study Design
Cross Sectional Study,Cohort Study,Longitudinal Study
Study Approach
Country of Study
Publication Country
England